Division of Global Health (IHCAR), Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
BMC Infect Dis. 2011 Jan 28;11:32. doi: 10.1186/1471-2334-11-32.
Diarrhoea accounts for 20% of all paediatric deaths in India. Despite WHO recommendations and IAP (Indian Academy of Paediatrics) and Government of India treatment guidelines, few children suffering from acute diarrhoea in India receive low osmolarity oral rehydration solution (ORS) and zinc from health care providers. The aim of this study was to analyse practitioners' prescriptions for acute diarrhoea for adherence to treatment guidelines and further to determine the factors affecting prescribing for diarrhoea in Ujjain, India.
This cross-sectional study was conducted in pharmacies and major hospitals of Ujjain, India. We included prescriptions from all practitioners, including those from modern medicine, Ayurveda, Homeopathy as well as informal health-care providers (IHPs). The data collection instrument was designed to include all the possible medications that are given for an episode of acute diarrhoea to children up to 12 years of age. Pharmacy assistants and resident medical officers transferred the information regarding the current diarrhoeal episode and the treatment given from the prescriptions and inpatient case sheets, respectively, to the data collection instrument.
Information was collected from 843 diarrhoea prescriptions. We found only 6 prescriptions having the recommended treatment that is ORS along with Zinc, with no additional probiotics, antibiotics, racecadotril or antiemetics (except Domperidone for vomiting). ORS alone was prescribed in 58% of the prescriptions; while ORS with zinc was prescribed in 22% of prescriptions, however these also contained other drugs not included in the guidelines. Antibiotics were prescribed in 71% of prescriptions. Broad-spectrum antibiotics were prescribed and often in illogical fixed-dose combinations. One such illogical combination, ofloxacin with ornidazole, was the most frequent oral antibiotic prescribed (22% of antibiotics prescribed). Practitioners from alternate system of medicine and IHPs are significantly less likely (OR 0.13, 95% CI 0.04-0.46, P = 0.003) to prescribe ORS and zinc than pediatricians. Practitioners from 'free' hospitals are more likely to prescribe ORS and zinc (OR 4.94, 95% CI 2.45-9.96, P < 0.001) and less likely to prescribe antibiotics (OR 0.01, 95% CI 0.01-0-04, P < 0.001) compared to practitioners from 'charitable' hospitals. Accompanying symptoms like the presence of fever, pain, blood in the stool and vomiting significantly increased antibiotic prescribing.
This study demonstrated low adherence to standard treatment guidelines for management of acute diarrhoea in children under 12 years in Ujjain, India. Key public health concerns were the low use of zinc and the high use of antibiotics, found in prescriptions from both specialist paediatricians as well as practitioners from alternate systems of medicine and informal health-care providers. To improve case management of acute diarrhoea, continuing professional development programme targeting the practitioners of all systems of medicine is necessary.
在印度,腹泻导致 20%的儿科死亡。尽管世界卫生组织(WHO)的建议以及印度儿科学会(IAP)和印度政府的治疗指南都有推荐,但印度很少有急性腹泻患儿能从卫生保健提供者那里获得低渗口服补液盐(ORS)和锌。本研究旨在分析从业者治疗急性腹泻的处方,以确定其是否符合治疗指南,并进一步确定影响乌贾因(印度城市名)腹泻处方的因素。
本横断面研究在印度乌贾因的药店和主要医院进行。我们纳入了所有从业者的处方,包括现代医学、阿育吠陀医学、顺势疗法以及非正式医疗保健提供者(IHPs)。数据收集工具设计用于收集所有可能用于治疗 12 岁以下儿童急性腹泻的药物。药剂师助理和住院医师从处方和住院病历中分别记录当前腹泻发作和治疗信息。
共收集了 843 张腹泻处方。我们仅发现 6 张处方包含符合推荐的治疗方案,即 ORS 加锌,无额外使用益生菌、抗生素、洛哌丁胺或止吐药(除了用于呕吐的多潘立酮)。58%的处方仅开具了 ORS;22%的处方开具了 ORS 加锌,但也包含了指南中未推荐的其他药物。71%的处方开具了抗生素。广谱抗生素被广泛使用,且经常以不合理的固定剂量组合使用。其中一种不合理的组合,氧氟沙星和奥硝唑,是最常开的口服抗生素(占抗生素处方的 22%)。与儿科医生相比,来自替代医学体系和 IHPs 的从业者开具 ORS 和锌的可能性明显较低(OR 0.13,95%CI 0.04-0.46,P = 0.003)。与来自“慈善”医院的从业者相比,来自“免费”医院的从业者更有可能开具 ORS 和锌(OR 4.94,95%CI 2.45-9.96,P < 0.001),且不太可能开具抗生素(OR 0.01,95%CI 0.01-0.04,P < 0.001)。伴随发烧、疼痛、粪便带血和呕吐等伴随症状的出现,抗生素的开具比例显著增加。
本研究表明,印度乌贾因 12 岁以下儿童急性腹泻的治疗标准与管理指南的依从性较低。主要的公共卫生问题是锌的使用不足和抗生素的使用过高,这在专科儿科医生和替代医学体系以及非正式医疗保健提供者的处方中都有体现。为了改善急性腹泻的病例管理,需要针对所有医学体系的从业者开展持续的专业发展计划。